SGLT2 inhibitors reduce epicardial adipose tissue more than GLP-1 agonists or exercise interventions in patients with type 2 diabetes mellitus and/or obesity: A systematic review and network meta-analysis

Año publicación: 2024

Subir documento: https://drive.google.com/file/d/1wSszkO12i0UciytRloXItkB8ni8ztg6X/view?usp=sharing

Nombre investigadores: Yu Bao, Yucai Hu, Menglong Shi, Zhiqiang Zhao